Purpose Of Review: To review recent trials and reassess cardiovascular risk in people with diabetes.
Recent Findings: Recent clinical trials have tended to focus on lower-risk participants with diabetes who have had event rates considerably lower than participants in the early lipid trials. Statin studies have generally shown benefit in those without cardiovascular disease and at lower levels of low-density lipoprotein cholesterol.